Colorectal Cancer Therapeutics Market Share

Report ID: GMI9808
   |
Published Date: June 2024
 | 
Report Format: PDF

Download Free PDF

Colorectal Cancer Therapeutics Market Share

The competitive landscape of the colorectal cancer therapeutics industry is marked by intense rivalry among major pharmaceutical companies and biotech firms, each striving to gain a significant foothold in the market. Key players leverage their extensive portfolios and innovative treatment approaches to maintain a competitive edge.
 

Colorectal Cancer Therapeutics Market Companies

Prominent players operating in the colorectal cancer therapeutics industry include:

  • Amgen Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Celleron Therapeutics
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Genentech, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sumitomo Pharma Co., Ltd.
  • Regeneron Pharmaceuticals, Inc.
  • TAIHO PHARMACEUTICAL CO., LTD
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
How much is the colorectal cancer therapeutics market worth?
The market size of colorectal cancer therapeutics reached USD 12.4 billion in 2023 and is set to witness 4.6% CAGR through 2032, owing to rising incidence rates, as well as advancements in targeted and cancer immunotherapy.
Why is the demand for colorectal adenocarcinoma therapeutics rising?
Why is the colorectal cancer therapeutics market booming in North America?
Who are the major colorectal cancer therapeutics industry players?
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2023

    Companies covered: 15

    Tables & Figures: 206

    Countries covered: 22

    Pages: 114

    Download Free PDF

    Top